Albany - New York, Nov. 6, 2015 (GLOBE NEWSWIRE) -- A new Transparency Market Research report states that the global in vitro toxicity testing market was valued at US$1.5 bn in 2011 and is predicted to reach US$4.1 bn by 2018. The market will expand at a healthy 15.30% CAGR between 2012 and 2018. The title of the report is "In Vitro Toxicity Testing Market - Global Industry Size, Share, Trends, Analysis and Forecast 2012 - 2018".
Browse Market Research Report on In Vitro Toxicity Testing Market: http://www.transparencymarketresearch.com/in-...arket.html
According to this report, the in vitro toxicity testing market is majorly fuelled by the exponential population and economic growth of developing nations and the rising health-consciousness amongst individuals. In addition, regulatory concerns about toxicity testing are poised to propel the market. Even though this market is still an emerging market, emergence of a large number of technological advancements and the introduction of new products in the in vitro toxicity testing market will boost the market in the coming years. In vitro toxicology has a number of advantages: it is less time-consuming than conventional toxicity testing and more cost-effective in comparison to other animal testing methods. These factors will stimulate the market for in vitro toxicity testing in the forthcoming years.
Get Sample Report Copy of In Vitro Toxicity Testing Market: http://www.transparencymarketresearch.com/sam...rep_id=395
On the basis of type, the vitro toxicity testing market is segmented into absorption, dose, and toxic substances. The segment of absorption includes metabolism, distribution, and excretion. The segment of dose includes threshold response and dose response. The segment of toxic substances includes toxicant, acute and chronic toxicity, and toxicokinetics.
Browse Press Release of In Vitro Toxicity Testing Market: http://www.transparencymarketresearch.com/pre...market.htm
On the basis of application, the market is segmented into in vitro toxicity testing methods and cytotoxicity assays used in vitro toxicity testing. On the basis of end use, the market is segmented into the pharmaceutical industry, cosmetics and household products, the chemicals industry, and the food and beverages industry.On the basis of geography, the in vitro toxicity testing market is segmented into Europe, North America, Asia, and Rest of the World. Amongst these, in 2010, the largest share was held by North America, which constituted approximately 40% of the market, having a value of US$526.9 million. This region will maintain its superiority throughout the forecasting horizon, but Europe will gradually overtake the North America market and will hold the biggest share by 2018. The prime reason for the dominance of Europe is the high prevalence of cosmetic product testing in this region. In addition, researchers are using in vitro toxicity testing methods for analysis of genotoxic effects owing to the ban on animal testing
The lack of pharmaceutical giants within this market presents lucrative opportunities for new entrants to carve out a dominating position in the market. Thus, the companies that are ready for investment in this emerging market are poised to establish themselves due to the fact that this market presents a huge scope for new participants. Players dominant in the market include WApredica (Acquired By Cyprotex), Accelrys Software Inc., Bio-Rad Laboratories, Covance Inc., Gene Logic Inc., Charles River, Laboratories International Inc., In Vitro Technologies, Molecular Toxicology Inc., Mattek Corporation, MB Research Laboratories, SBW Ltd., RTI Health Solutions, Xenometrix, and Xenobiotic Detection Systems (XDS), among others.
Browse Upcoming Market Research Reports:
- Infectious Diseases in Vitro Diagnostics (IVD) Market: http://www.transparencymarketresearch.com/inf...stics.html
- BRIC In-Vitro Diagnostics (IVD) Market: http://www.transparencymarketresearch.com/bri...stics.html
- Laboratory-Developed Testing Market: http://www.transparencymarketresearch.com/lab...arket.html
The market has been segmented as follows:
In Vitro Toxicity Testing Market by End Use
- Cosmetics and Household Products
- Pharmaceutical Industry
- Food Industry
- Chemicals Industry
In Vitro Toxicity Testing Market by Application
- In Vitro Toxicity Testing Methods
- Cytotoxicity Essays Uses for In Vitro Toxicity Testing
In Vitro Toxicity Market by Type
By Absorption
- Distribution
- Metabolism
- Excretion
By Dose
- Dose Response
- Threshold Response
By Toxic Substances
- Toxicant
- Toxin
- Acute and Chronic Toxicity
- Toxicokinetics
The geographies covered in this report include:
- North America
- Europe
- Asia
- Rest of the World
Other Related Market Research Reports:
1. In Vitro Diagnostics Market to Expand Rapidly in Developing Countries due to Presence of Unmet Needs
Transparency Market Research has published a new report that offers an in-depth study of the global metrology services market. The report, titled "In Vitro Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2012 - 2018", is available for sale on the company's website. This report offers a 360-degree view of the global in vitro diagnostics market along with an assessment of the strengths, weaknesses, opportunities, and threats faced by this market.
The global in vitro diagnostics market has been segmented on the basis of products and geography. In terms of geography, this market can be divided into Asia Pacific, Europe, North America, and Rest of the World. The products in the global in vitro diagnostics market are clinical chemistry IVDs, immunoassay IVDs, blood testing IVDs, molecular diagnostics, diabetes testing IVDs, and other IVDs.
Get Sample Report: http://www.transparencymarketresearch.com/sam...ep_id=1395
2. In-Vitro Cancer Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023
Cancer is a collection of different diseases that are caused by various genetic malfunctions. Cancer results from uncontrolled growth of cells of various organs and tissues. There are more than 100 different types of cancer, and each cancer type is classified based on the type of cell that gets initially affected. Cancer harms the patients when damaged cells split uncontrollably to form masses or lumps of tissue. These masses are called as tumors. Tumors can easily grow and interfere with the nervous, digestive, and circulatory systems. Tumor cells release hormones that are efficient in altering body functions. Tumors that stay in one spot and demonstrate limited growth are generally considered to be benign tumors. Benign tumor is not harmful but when it grows and form malignant tumor, become fatal to body.
Get Sample Report: http://www.transparencymarketresearch.com/sam...ep_id=4739
About Us:
Transparency Market Research (TMR) is a U.S. based provider of syndicated research, customized research, and consulting services. TMR's global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.
Mr. Nachiket Ghumare 90 State Street, Suite 700 Albany, NY 12207 United States. Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: sales@transparencymarketresearch.com Website: http://www.transparencymarketresearch.com Blog: http://www.tmrblog.com/
